Sussex Research Laboratories Inc. to Exhibit at Glyco26 in Taipei, Taiwan

Date published: August 14, 2023

Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce that we are exhibiting at the 26th International Glycoconjugate Symposium (IGS) - Glyco26 in Taipei, Taiwan! Visit us at booth 7 and meet our VP of Chemistry, Dr. Fengyang Yan from August 27th until September 1st, 2023.

For over 25 years, we have enabled application of complex carbohydrate systems, including GalNAc and glycopeptides, in drug discovery, drug delivery, drug targeting, glycoconjugate vaccine development, immunotherapy, therapeutic enhancement and diagnostic/bio-analytical assay development. 

About Sussex Research Laboratories Inc.: Sussex Research Laboratories Inc. is a global leader in Carbohydrate Synthesis. We excel at translating complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit glycobiology in applications that promote human health. Our product portfolio and contract research & development services enable our clients and partners to apply discoveries in glycomics for drug development & discovery, drug delivery & targeting, vaccine development and monoclonal antibody development. Experience glyco-enhancement of your small molecule, protein, oligonucleotide or other macromolecule through Sussex Research Laboratories Inc.. We are the GalNAc, Glycan, Ligand, Glycopeptide and Glycoconjugate Specialists. For more information visit www.sussex-research.com.

SHARE THIS ARTICLE ON: